Prognostic genes/model | Univariate Cox Analyses | Multivariate Cox Analyses | Sample size | Refs. | ||
---|---|---|---|---|---|---|
HR (95 CI%) | P | HR (95 CI%) | P | |||
OC | ||||||
WTAP | NA | P = 0.021 | 1.191 (1.023–1.385) | P = 0.024 | 231 | [84] |
YTHDC2 and KIAA1429 | 3.143 (1.516–6.517) | P = 0.002 | 2.330 (1.116–4.865) | P = 0.024 | 379 | [88] |
IGF2BP1, VIRMA and ZC3H13 | 1.25 (1.10–1.43) | P < 0.001 | 1.24 (1.08–1.41) | P = 0.002 | 379 | [86] |
VIRMA, IGF2BP1, and HNRNPA2B1 | 1.62 (1.20–2.20) | P = 0.002 | 1.60 (1.18–2.17) | P = 0.003 | 374 | [87] |
WTAP, LGR6, ZC2HC1A, SLC4A8, AP2A1, NRAS, CUX1, HDAC1, CD79A, ACE2, FLG2, and LRFN1 | 1.664 (1.481–1.868) | P = 8.5E-18 | 1.699 (1.508–1.913) | P = 2.29E-18 | 373 | [89] |
CC | ||||||
HNRNPC, KIAA1429, ZC3H13 | 2.268 (1.161–4.431) | P = 0.017 | 2.583 (1.289–5.174) | P = 0.007 | 306 | [155] |
ZC3H13, YTHDC1, and YTHDF1 | NA | NA | 4.592 (2.788–7.562) | P < 0.001 | 304 | [156] |
EC | ||||||
FTO, RBM15, and YTHDF1 | 1.129 (1.065–1.197) | P < 0.001 | 1.090 (1.023–1.161) | P = 0.008 | 406 | [205] |
7 CpG sites (cg13823621, cg08881614, cg07867023, cg22247039, cg00624976 cg06778680 and, cg13204529) | NA | NA | 4.3 (2.4–7.6) | P < 0.001 | 312 | [206] |